Ep40: Taking DTx to Market: Nate Beyor Gives Insights On Building Teams and Products

In this episode, we hear from Nate Beyor, managing director and partner of BCG healthcare. We dive into many topics around digital therapeutics and get a bird's eye view across BCG's customer base.

In this episode, we cover:

New company creation: large company spin-outs vs entrepreneurs 

What it takes to build a team that can take a digital therapeutic to market

Why build rather than buy a new DTx

Approaching medical pharma clients vs approaching smaller DTx companies

Go to market strategy and value creation: Standalone vs Drug+

Embedding clinical decision support into workflows


Guest Links and Resources:

Connect with Nate Beyor on: LinkedIn


Visit: www.bcg.com/


Host Links:

Connect with Eugene Borukhovich: Twitter | LinkedIn


Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn


Connect with YourCoach.health: Website | Twitter


Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App


HealthXL: Website | Twitter | Join an Event




Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:
> Presenting Partner: Amalgam Rx
> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health

Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram